Skip to main content
SpringerLink
Log in

ALK-positive Lungenkarzinome: Längeres Gesamtüberleben

  • Literatur kompakt_Tumoren der Lunge
  • Published:
Im Focus Onkologie Aims and scope

Bei einigen der Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) lässt sich eine ALK-Genfusion nachweisen. Nun wurden Prävalenz und prognostischer Wert der Genveränderung untersucht.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Blackhall FH et al. Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platorm Lungscape Project. J Clin Oncol. 2014;32(25):2780–2787.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Barbara Kreutzkamp

Authors
  1. Barbara Kreutzkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kreutzkamp, B. ALK-positive Lungenkarzinome: Längeres Gesamtüberleben. Im Focus Onkologie 18, 29 (2015). https://doi.org/10.1007/s15015-015-1850-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15015-015-1850-x

Search

Navigation